ADMA BIOLOGICS, INC. Quarterly Nonoperating Income (Expense) in USD from Q1 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Adma Biologics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2011 to Q3 2024.
  • Adma Biologics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$2.89M, a 52.8% increase year-over-year.
  • Adma Biologics, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$41.5M, a 71.9% decline year-over-year.
  • Adma Biologics, Inc. annual Nonoperating Income (Expense) for 2023 was -$49.9M, a 87.9% decline from 2022.
  • Adma Biologics, Inc. annual Nonoperating Income (Expense) for 2022 was -$26.5M, a 99.9% decline from 2021.
  • Adma Biologics, Inc. annual Nonoperating Income (Expense) for 2021 was -$13.3M, a 22.5% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$41.5M -$2.89M +$3.23M +52.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$44.8M -$3.35M +$2.55M +43.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$47.3M -$3.42M +$2.56M +42.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$49.9M -$31.9M -$25.7M -416% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 -$24.2M -$6.12M -$537K -9.62% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$23.6M -$5.9M -$1.31M -28.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$22.3M -$5.98M +$4.22M +41.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$26.5M -$6.17M -$2.71M -78.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 -$23.8M -$5.58M -$2.31M -70.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$21.5M -$4.59M -$1.27M -38.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$20.3M -$10.2M -$6.98M -217% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 -$13.3M -$3.46M -$1.27M -58.1% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 -$12M -$3.28M -$159K -5.12% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$11.8M -$3.32M -$270K -8.83% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 -$11.6M -$3.22M -$740K -29.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 -$10.8M -$2.19M +$547K +20% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-24
Q3 2020 -$11.4M -$3.12M -$728K -30.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$10.7M -$3.05M -$1.18M -63.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 -$9.47M -$2.48M -$2.62M -1862% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 -$6.85M -$2.73M -$1.24M -83.5% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-25
Q3 2019 -$5.61M -$2.39M -$1.04M -77.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$4.57M -$1.87M -$543K -40.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 -$4.02M $140K +$1.43M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 -$5.45M -$1.49M +$949K +38.9% Oct 1, 2018 Dec 31, 2018 10-K 2019-03-13
Q3 2018 -$6.4M -$1.34M -$569K -73.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 -$5.83M -$1.33M -$696K -110% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$5.14M -$1.29M -$690K -115% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 -$4.45M -$2.44M -$1.82M -297% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-13
Q3 2017 -$2.62M -$775K -$181K -30.4% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 -$2.44M -$635K -$113K -21.7% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-10
Q1 2017 -$2.33M -$600K -$146K -32.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q4 2016 -$2.18M -$615K -$163K -36.1% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-29
Q3 2016 -$2.02M -$594K -$156K -35.6% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-03
Q2 2016 -$1.87M -$521K +$641K +55.1% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-11
Q1 2016 -$2.51M -$454K -$50.7K -12.6% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
Q4 2015 -$2.46M -$452K -$45.9K -11.3% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-24
Q3 2015 -$2.41M -$438K -$91.8K -26.5% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 -$2.32M -$1.16M -$789K -211% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-12
Q1 2015 -$1.53M -$403K -$183K -83.4% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 -$1.35M -$406K -$223K -122% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-23
Q3 2014 -$1.12M -$346K -$188K -119% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-10
Q2 2014 -$935K -$374K -$322K -615% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-11
Q1 2014 -$613K -$220K -$128K -140% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-12
Q4 2013 -$485K -$183K -$1.6M -113% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-09
Q3 2013 $1.11M -$158K -$161K -5241% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 $1.27M -$52.3K -$52.1K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-11
Q1 2013 $1.33M -$91.6K +$1.34M +93.6% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 -$9.76K $1.41M Oct 1, 2012 Dec 31, 2012 10-K 2014-03-28
Q3 2012 $3.07K +$216K Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 -$175* +$240K Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-12
Q1 2012 -$1.43M -$1.11M -352% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-14
Q3 2011 -$213K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
Q2 2011 -$240K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 -$315K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.